On January 3, 2024, the quadrivalent influenza virus lysate vaccine independently developed by Wuhan Institute of Biological Products of China Biologicals (WIBP) was granted a certificate of drug registration by the Ministry of Health and Prevention (MOHAP) of the United Arab Emirates (UAE). This is another international registration certificate obtained after the Kenyan registration certificate in 2023, marking the steady progress of the internationalization strategy of Wuhan Bioproducts Research Institute and the gradual opening of a new channel for exporting vaccine products to the Middle East.

Influenza is an acute respiratory infectious disease caused by influenza virus. According to WHO's estimation, about 600 million people are infected with influenza virus globally every year, and as many as 250,000 to 500,000 cases of death. Influenza vaccination is the most cost-effective preventive measure. Influenza vaccine of Wuhan Institute of Biological Products is prepared by a patented process without antibiotics and preservatives. It is the first one in China to carry out clinical trials on people over 60 years old and obtain data support, and its products have high purity and low impurity content, with good safety and effectiveness. At present, Wuhan Institute of Biological Products has an intelligent and automated influenza vaccine production workshop, which can guarantee the continuous and stable production of the product.

The overseas export of Wuhan Biological Products Research Institute's quadrivalent influenza virus lysate vaccine is another fruitful achievement of the flourishing international cooperation of "One Belt, One Road". As a national technology innovation demonstration enterprise, Wuhan Institute of Biological Products shoulders love and responsibility, adheres to the concept of "blessing life, caring for health", insists on the development strategy of basing on the domestic market and actively exploring the international market, and makes greater contribution to safeguarding people's health and promoting the construction of a community of human destiny.

https://mp.weixin.qq.com/s/mNsAE2mDQ5-puRT9aAgpuA